Molecular imaging is a new discipline that makes possible the noninvasive visualization of cellular and molecular processes in living subjects. Here we will adopt the reporter gene and reporter probe imaging technique (developed initially for cancer researchers) to solve a different important problem in cardiology (i.e., understand pharmacokinetics and biodistribution of cardiac stem cell transplantation). However, the Achilles? heel of reporter gene imaging has always been random integration into cellular chromosomes. Here we will develop 4 novel genome editing approaches (ZFN, TALEN, CRISPR, phiC31) that will enable us to safely and efficiently introduce human PET reporter gene (hmTK2) into human induced pluripotent stem cells (iPSCs). These cell types are chosen because of the recent discovery that adult somatic cells can be transformed into iPSCs that acquire both unlimited self-renewal and pluripotent differentiation (similar to human embryonic stem cells). We will perform comprehensive characterization of these genome edited lines. Upon validation, we will subsequently image in vivo fate of iPSC-CMs in both small and large animal myocardial infarction models to understand the biological effects of cell dosage, timing of delivery, and imaging sensitivity. We will correlate iPSC-CM survival by PET reporter gene imaging and cardiac function by magnetic resonance imaging. The information gathered from these studies should prove instrumental for marrying molecular imaging with clinical stem cell therapy in the future.

Public Health Relevance

Coronary artery disease (CAD) is a progressive disease with high morbidity and mortality rates in the US. Following myocardial infarction (MI), the limited ability of the surviving cardiac cells to proliferate renders the damaged heart susceptible to unfavorable remodeling processes and morbid sequelae such as heart failure. In recent years, stem cell therapy has emerged as a promising candidate for treating ischemic heart disease as evident by the multiple clinical trials that have been undertaken. Thus, development of novel technologies to image cell fate and cardiac function is a high priority in both basic research and clinical translation. Our major goals for this R01 grant are to develop novel genome editing approaches for introducing PET reporter gene to human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) and to improve the therapeutic strategies of stem cell therapy as guided by imaging. Importantly, the overall experience we gain here will be extremely valuable for eventual clinical translation of cardiac stem cell imaging in the future.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL133272-05
Application #
9924281
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Luo, James
Project Start
2016-07-21
Project End
2021-04-30
Budget Start
2020-05-01
Budget End
2021-04-30
Support Year
5
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Stanford University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Lee, Andrew S; Inayathullah, Mohammed; Lijkwan, Maarten A et al. (2018) Prolonged survival of transplanted stem cells after ischaemic injury via the slow release of pro-survival peptides from a collagen matrix. Nat Biomed Eng 2:104-113
Zhao, Xin; Chen, Haodong; Xiao, Dan et al. (2018) Comparison of Non-human Primate versus Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Treatment of Myocardial Infarction. Stem Cell Reports 10:422-435
Cao, Y; Chen, H; Qiu, R et al. (2018) Universal intracellular biomolecule delivery with precise dosage control. Sci Adv 4:eaat8131
Oikonomopoulos, Angelos; Kitani, Tomoya; Wu, Joseph C (2018) Pluripotent Stem Cell-Derived Cardiomyocytes as a Platform for Cell Therapy Applications: Progress and Hurdles for Clinical Translation. Mol Ther 26:1624-1634
Qin, Xulei; Chen, Haodong; Yang, Huaxiao et al. (2018) Photoacoustic Imaging of Embryonic Stem Cell-Derived Cardiomyocytes in Living Hearts with Ultrasensitive Semiconducting Polymer Nanoparticles. Adv Funct Mater 28:
Ong, Sang-Ging; Lee, Won Hee; Zhou, Yang et al. (2018) Mining Exosomal MicroRNAs from Human-Induced Pluripotent Stem Cells-Derived Cardiomyocytes for Cardiac Regeneration. Methods Mol Biol 1733:127-136
Namavari, Mohammad; Gowrishankar, Gayatri; Srinivasan, Ananth et al. (2018) A novel synthesis of 6''-[18 F]-fluoromaltotriose as a PET tracer for imaging bacterial infection. J Labelled Comp Radiopharm 61:408-414
Abilez, Oscar J; Tzatzalos, Evangeline; Yang, Huaxiao et al. (2018) Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling. Stem Cells 36:265-277
Kooreman, Nigel G; Kim, Youngkyun; de Almeida, Patricia E et al. (2018) Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo. Cell Stem Cell 22:501-513.e7
Nishiga, Masataka; Guo, Hongchao; Wu, Joseph C (2018) Induced pluripotent stem cells as a biopharmaceutical factory for extracellular vesicles. Eur Heart J 39:1848-1850

Showing the most recent 10 out of 26 publications